By David Tuller, DrPH I met Valerie Eliot Smith a year or so before I published my 15,000-word investigation of the PACE trial. As an experienced lawyer familiar with how libel and related torts are handled in the UK, she provided invaluable advice on legal issues. (She and her husband also suggested the name “Trial …
Trial By Error: Valerie Eliot Smith on COVID-19, ME and Legal Repercussions Read More »
By David Tuller, DrPH The graded exercise therapy/cognitive behavior therapy treatment paradigm for chronic fatigue syndrome, also imposed on those diagnosed with myalgic encephalomyelitis, CFS/ME, ME/CFS, and other variants–is like the undead. This concept keeps reemerging from the fetid intellectual swamplands that spawned it, no matter how many times it is revealed as nonsense.
By David Tuller, DrPH Last year, Archives of Disease in Childhood slapped a 3000-word correction on a University of Bristol study of the Lightning Process. The lead investigator was Bristol’s ethically and methodologically challenged pediatrician, Professor Esther Crawley, who failed to disclose to the journal that the study had violated core scientific principles.
By David Tuller, DrPH A few weeks ago, the Oxford Health NHS Foundation Trust posted a pamphlet about coronavirus and fatigue that could have been written by the GET/CBT ideological brigades in the 1990s. It was attributed to–or blamed on?–a mysterious entity called the “psychosocial response group.” No information about these psychosocialists was available on …
Trial By Error: Oxford Health’s Response to My Freedom of Information Request Read More »
By David Tuller, DrPH One of Mahana Therapeutics’ business advisers is Dr Harpreet Sood, identified as the National Health Service’s associate chief clinical information officer. (Actually, Mahana seems to have it wrong; it looks like Dr Sood is still be at the NHS but moved on a while ago to another position. I guess accuracy …
Trial By Error: A Letter to Mahana’s NHS-Linked Business Adviser Read More »
By David Tuller, DrPH Back in February, I wrote to some science advisers to Mahana Therapeutics to alert them to the company’s unjustified claims about the impact of its web-based program on the symptoms of irritable bowel syndrome. Two of them–Dr Peter Lu and Dr Carlo di Lorenzo–are gastroenterology specialists at Nationwide Children’s Hospital in …
Trial By Error: Another Nudge to Mahana’s Gasteroenterology Advisers Read More »
